Cytokinetics
CYTK
CYTK
95 hedge funds and large institutions have $254M invested in Cytokinetics in 2016 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 24 increasing their positions, 40 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
40% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 40
62% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 21
Holders
95
Holding in Top 10
3
Calls
$1.35M
Puts
$919K
Top Buyers
| 1 | +$12M | |
| 2 | +$11.3M | |
| 3 | +$6.15M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$4.78M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.18M |
Top Sellers
| 1 | -$8.44M | |
| 2 | -$2.94M | |
| 3 | -$2.16M | |
| 4 |
MCM
Matarin Capital Management
New York
|
-$2.15M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$2.13M |